• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 25-羟维生素 D 水平并不影响甲状腺乳头状癌的侵袭性和预后。

Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer.

机构信息

1 Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine , Seoul, Korea.

2 Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine , Seoul, Korea.

出版信息

Thyroid. 2016 Mar;26(3):429-33. doi: 10.1089/thy.2015.0516. Epub 2016 Feb 9.

DOI:10.1089/thy.2015.0516
PMID:26739552
Abstract

BACKGROUND

Vitamin D deficiency has been known to be associated with the aggressiveness and prognosis of several cancers. This study evaluated the effect of preoperative serum vitamin D levels on the aggressiveness and prognosis of papillary thyroid cancer (PTC).

METHODS

In total, 820 patients with PTC were enrolled. 25-hydroxyvitamin D levels were measured in blood samples before surgery. Clinical, pathologic, and recurrence data were accessed to examine the prognostic effects of vitamin D. Patients were categorized into four quartiles by preoperative serum vitamin D levels.

RESULTS

Of the enrolled patients, 795 (97%) had insufficient vitamin D levels (<30 ng/mL). Vitamin D levels showed positive correlations with age and body mass index (BMI), and negative correlations with serum thyrotropin levels and antithyroid peroxidase antibody titers. The association between vitamin D quartile and the risks of extrathyroidal invasion, lymph node metastasis, advanced cancer stages (III or IV), and risk of recurrence were not significant after adjusting for age, sex, BMI, preoperative ionized calcium, and parathyroid hormone. Additionally, serum vitamin D was not associated with recurrent or persistent PTC.

CONCLUSION

Serum vitamin D levels are not associated with either disease aggressiveness or poor outcomes among patients with PTC and vitamin D insufficiency.

摘要

背景

维生素 D 缺乏与多种癌症的侵袭性和预后有关。本研究评估了术前血清维生素 D 水平对甲状腺乳头状癌(PTC)侵袭性和预后的影响。

方法

共纳入 820 例 PTC 患者。在术前采集血样检测 25-羟维生素 D 水平。查阅临床、病理和复发数据,以检验维生素 D 的预后作用。根据术前血清维生素 D 水平将患者分为四组。

结果

820 例患者中,795 例(97%)存在维生素 D 不足(<30ng/mL)。维生素 D 水平与年龄和体重指数(BMI)呈正相关,与促甲状腺激素水平和抗甲状腺过氧化物酶抗体滴度呈负相关。在校正年龄、性别、BMI、术前离子钙和甲状旁腺激素后,维生素 D 四分位组与甲状腺外侵犯、淋巴结转移、晚期癌症分期(III 或 IV 期)和复发风险之间无显著关联。此外,血清维生素 D 与 PTC 复发或持续存在无关。

结论

在维生素 D 不足的 PTC 患者中,血清维生素 D 水平与疾病侵袭性或不良预后无关。

相似文献

1
Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer.血清 25-羟维生素 D 水平并不影响甲状腺乳头状癌的侵袭性和预后。
Thyroid. 2016 Mar;26(3):429-33. doi: 10.1089/thy.2015.0516. Epub 2016 Feb 9.
2
Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.血清25-羟维生素D水平低与女性乳头状甲状腺癌患者不良的临床病理特征相关。
Thyroid. 2014 Nov;24(11):1618-24. doi: 10.1089/thy.2014.0090. Epub 2014 Sep 19.
3
25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.25-羟基维生素D和促甲状腺激素作为甲状腺癌的危险因素或预后标志物
PLoS One. 2016 Oct 13;11(10):e0164550. doi: 10.1371/journal.pone.0164550. eCollection 2016.
4
The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.根据手术患者的体重指数,甲状腺乳头状癌的发病率及预后情况。
Surgery. 2014 Nov;156(5):1145-52. doi: 10.1016/j.surg.2014.04.020. Epub 2014 May 27.
5
Correlation between Pre-Operative 25-Hydroxyvitamin D Levels and Poor Prognostic Factors for Papillary Thyroid Cancer.术前25-羟基维生素D水平与甲状腺乳头状癌不良预后因素之间的相关性
J Invest Surg. 2022 May;35(5):1076-1082. doi: 10.1080/08941939.2021.2010842. Epub 2021 Dec 5.
6
[Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].淋巴细胞性甲状腺炎合并甲状腺乳头状癌的临床分析
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Apr 7;51(4):277-81. doi: 10.3760/cma.j.issn.1673-0860.2016.04.007.
7
Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.伴淋巴结转移的甲状腺乳头状癌术后复发
J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.
8
Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma.甲状腺乳头状癌患者的术前亚临床甲状腺功能减退症。
Am J Otolaryngol. 2013 Jul-Aug;34(4):312-9. doi: 10.1016/j.amjoto.2012.12.013. Epub 2013 Jan 26.
9
Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.复发性甲状腺乳头状癌的再次淋巴结清扫术及其对血清甲状腺球蛋白的影响。
Ann Surg Oncol. 2012 Sep;19(9):2951-7. doi: 10.1245/s10434-012-2380-9. Epub 2012 Apr 24.
10
Vitamin D deficiency and its relationship to cancer stage in patients who underwent thyroidectomy for papillary thyroid carcinoma.甲状腺癌患者行甲状腺切除术术后维生素 D 缺乏及其与癌症分期的关系。
Am J Otolaryngol. 2019 Jul-Aug;40(4):536-541. doi: 10.1016/j.amjoto.2019.04.013. Epub 2019 Apr 22.

引用本文的文献

1
Association between vitamin D status and thyroid cancer: a meta-analysis.维生素D状态与甲状腺癌之间的关联:一项荟萃分析。
Front Nutr. 2024 Jun 18;11:1423305. doi: 10.3389/fnut.2024.1423305. eCollection 2024.
2
Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer.血清25-羟维生素D水平与甲状腺乳头状癌侵袭性的关联
Endocr Connect. 2023 Dec 12;13(1). doi: 10.1530/EC-23-0373. Print 2024 Jan 1.
3
Vitamin D and the Thyroid: A Critical Review of the Current Evidence.维生素 D 与甲状腺:当前证据的批判性回顾。
Int J Mol Sci. 2023 Feb 10;24(4):3586. doi: 10.3390/ijms24043586.
4
VITAMIN D LEVEL AND ITS RELATIONSHIP WITH CANCER STAGE IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA.分化型甲状腺癌患者的维生素D水平及其与癌症分期的关系。
Acta Endocrinol (Buchar). 2022 Apr-Jun;18(2):168-173. doi: 10.4183/aeb.2022.168.
5
Low Vitamin D Status is Not Associated with the Aggressive Pathological Features of Papillary Thyroid Cancer.低维生素D状态与甲状腺乳头状癌的侵袭性病理特征无关。
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):132-136. doi: 10.14744/SEMB.2022.36048. eCollection 2022.
6
Vitamin D Receptor Expression and its Clinical Significance in Papillary Thyroid Cancer.维生素D受体在甲状腺乳头状癌中的表达及其临床意义
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221089933. doi: 10.1177/15330338221089933.
7
Serum 25-hydroxyvitamin D level is unreliable as a risk factor and prognostic marker in papillary thyroid cancer.血清25-羟维生素D水平作为甲状腺乳头状癌的危险因素和预后标志物并不可靠。
Ann Transl Med. 2022 Feb;10(4):193. doi: 10.21037/atm-22-10.
8
Relationship Between Vitamin D and Thyroid: An Enigma.维生素D与甲状腺之间的关系:一个谜团。
Cureus. 2022 Jan 10;14(1):e21069. doi: 10.7759/cureus.21069. eCollection 2022 Jan.
9
The Role of Vitamin D as a Prognostic Marker in Papillary Thyroid Cancer.维生素D作为甲状腺乳头状癌预后标志物的作用
Cancers (Basel). 2021 Jul 14;13(14):3516. doi: 10.3390/cancers13143516.
10
Analyses of the Association between Thyroid Cancer and Osteoporosis/Fracture Histories: A Cross-Sectional Study Using KoGES HEXA Data.甲状腺癌与骨质疏松/骨折史相关性的分析:一项基于 KoGES HEXA 数据的横断面研究。
Int J Environ Res Public Health. 2021 Apr 29;18(9):4732. doi: 10.3390/ijerph18094732.